Table 5 Toxicity profile of the synthesized compounds 2a-j using toxicity prediction, extensible protocol of Accelrys Discovery studio 4.5.

From: Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues

Compound

Aerobic Bio-Degradability

Ames Prediction

Carcinogenicity Potency in mouse

Carcinogenic Potency in rat

TOPKAT_Rat Oral LD50

(g/kg body weight)

TOPKAT_Rat Maximum Tolerated Dose_Feed

(g/kg body weight)

TOPKAT_Rat Maximum Tolerated Dose_Gavage

(g/kg body weight)

2a

Degradable

Non-Mutagen

NO

NO

0.704822

0.0811332

0.0818904

2b

Non-Degradable

Non-Mutagen

NO

NO

0.447766

0.083154

0.0685762

2c

Degradable

Non-Mutagen

NO

NO

6.1736

0.0429369

0.0838771

2d

Non-Degradable

Non-Mutagen

NO

NO

0.838456

0.0687107

0.0526526

2e

Non-Degradable

Non-Mutagen

NO

NO

2.13901

0.0444935

0.00920672

2f

Non-Degradable

Non-Mutagen

NO

NO

0.277806

0.0680889

0.00552672

2g

Degradable

Non-Mutagen

NO

NO

1.55518

0.173071

0.0428836

2h

Non-Degradable

Non-Mutagen

NO

NO

0.222574

0.276438

0.0268914

2i

Non-Degradable

Mutagen

NO

NO

4.71945

0.039854

0.0344951

2j

Non-Degradable

Non-Mutagen

NO

NO

0.665194

0.0623034

0.0211534